Q5: What are the GHK-Cu side effects I should know about
In the landmark Phase 3 VESALIUS-CV trial (12,000+ patients), adding Repatha to standard cholesterol-lowering therapy significantly reduced the risk of: Heart attacks Ischemic strokes Coronary deaths This makes Repatha the first PCSK9 inhibitor to demonstrate preventive benefits before heart disease strikes a true paradigm shift in cardiovascular care
These pathways are collectively referred to as the methylation cycle, the major activity of which is the transfer of methyl groups between molecules
For pain management specifically, it excels at promoting tendon and ligament healing, muscle repair and recovery, reduced pain perception, improved joint function, and accelerated healing of soft tissue injuries
[24] In mild cases, ascorbate and N -acetylcysteine have been shown to increase glutathione levels and increase erythrocyte production
Am J Surg 169(5):533538